Skip to content
Screener

AptarGroup ATR Pharma — Adjusted EBITDA

Similar metrics at other companies

Jones Lang LaSalle logo
JLLAdjusted EBITDA
$273.6M+21.7%
Adient logo
ADNTAdjusted EBITDA
$246M0.0%
Churchill Downs logo
CHDNAdjusted EBITDA
$477M+5.8%
Playtika Holding Corp. logo
PLTKAdjusted EBITDA
$188.3M-0.6%
Playtika Holding Corp. logo
PLTKAdjusted EBITDA
$188.3M-0.6%
PSK
PSKYStudios — Adjusted EBITDA
$164M—

Other financials

Income statement

See full
Revenue$982.9M+10.8%
Gross profit$351.9M+4.6%
Operating income$107.5M-5.2%
Net income$72.7M-7.8%
EPS (diluted)$1.12-4.3%

Balance sheet

See full
Cash & equivalents$225.0M+78.8%
Total debt$1.4B+32.7%
Total equity$2.6B+3.6%
Total assets$5.1B+12.6%

Cash flow

See full
Operating cash flow$118.7M+43.5%
CapEx$65.4M+15.0%
Free cash flow$53.3M+106%

Valuation

See full
Market cap$8.69B-4.7%
Enterprise value$9.9B-2.2%
P/E22.5×-0.8×
P/S2.3×-0.3×

Profitability

See full
Gross margin36.7%-1.6pp
Operating margin12.8%-1.2pp
Net margin10%-0.4pp
FCF margin8.4%-2.1pp

Returns & leverage

See full
Return on equity15%-0.2pp
Debt / equity0.5×+0.1×
Current ratio1.7×+0.4×

Where this comes from

Reported directly by AptarGroup in its filing.

Tagged under the XBRL concept atr:AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization.

The source filing: AptarGroup’s 10-Q, filed May 1, 2026.

Filed
May 1, 2026, 11:22 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000896622-26-000092
Three Months Ended March 31,20262025
Beauty(965)(1,891)
Closures188(532)
Adjusted EBITDA (1):
Pharma$146,223$142,450
Beauty40,48237,138
Closures23,65727,260
Adjusted EBITDA for Reportable Segments$210,362$206,848
Corporate & Other, unallocated(21,477)(23,511)

ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)

FAQ

What is AptarGroup's pharma — adjusted EBITDA?
AptarGroup (ATR) reported pharma — adjusted EBITDA of $146.22M in Q1 2026.
How has AptarGroup's pharma — adjusted EBITDA changed year-over-year?
AptarGroup's pharma — adjusted EBITDA increased by 2.6% year-over-year, from $142.45M to $146.22M.
What does pharma — adjusted EBITDA mean?
A measure of the segment's operational profitability, calculated by adding back depreciation, amortization, and other non-cash or non-recurring items to operating income. It provides a normalized view of the segment's ability to generate cash from operations.

Ask your AI about AptarGroup's pharma — adjusted ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude